PD

Palak Dinesh Jain

Director Director DIN 09050232
DIN 09050232 First appointment Oct 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2021
Shareholding value •••• Premium profile

About Palak Dinesh Jain

Data last updated:

Palak Dinesh Jain was a Director at Sarvesh Traders Private Ltd (2021–2025) and Director at Sanket Pharmaceuticals Pvt Ltd (2021–2025). The companies operate in Trading and Pharma.

DIN 09050232
Primary Designation Director
Industry Trading
First Appointment 01 Oct 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sarvesh Traders Private Ltd U51900MH1994PTC076697
Director01 Nov 20211994₹1.8 Lakh (FY 2025)Active
Sanket Pharmaceuticals Pvt Ltd U24239MH1983PTC031464
Director01 Oct 20211983₹2.71 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sarvesh Traders Private Ltd
Sanket Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Palak Dinesh Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Palak Dinesh Jain

Palak Dinesh Jain was first appointed on 01 Oct 2021 as Director at Sanket Pharmaceuticals Pvt Ltd.

Palak Dinesh Jain held 2 earlier board appointments: Sarvesh Traders Private Ltd (Director, 01 Nov 2021 to 03 May 2025); Sanket Pharmaceuticals Pvt Ltd (Director, 01 Oct 2021 to 03 May 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available